Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US16954306Application Date: 2018-12-19
-
Publication No.: US11286283B2Publication Date: 2022-03-29
- Inventor: Martin Braun , Amirreza Faridmoayer , Sabina Marietta Gerber , Markus Mueller
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Priority: GB1721576 20171221
- International Application: PCT/EP2018/085854 WO 20181219
- International Announcement: WO2019/121924 WO 20190627
- Main IPC: C07K1/00
- IPC: C07K1/00 ; C07K14/31 ; A61K47/64 ; A61K39/085 ; C12N9/10 ; A61K38/00

Abstract:
The present invention discloses modified Staphylococcus aureus HIa proteins which show reduced tendency to aggregate, improving protein stability and yield. Said modified HIa proteins optionally also contain glycosylation site consensus sequences. The invention also discloses a conjugate comprising a modified HIa protein and an antigen (for example a Staphylococcus aureus saccharide antigen), wherein the antigen is linked to an amino acid residue of the modified HIa protein.
Public/Granted literature
- US20210214402A1 IMMUNOGENIC COMPOSITION Public/Granted day:2021-07-15
Information query